These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23595948)

  • 21. Use of interferon beta 1b for multiple sclerosis. Manufacturer defends the drug.
    Longthorne PN
    BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939141
    [No Abstract]   [Full Text] [Related]  

  • 22. [A comparative analysis of rebif 22-mcg and copaxone efficacy in multiple sclerosis].
    Zavalishin IA; Peresedova AV; Stoĭda NI; Rebrova Oi; Zakharova MN; Adarcheva LS; Niazbekova AS; Askarova LSh; Baĭdina EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Spec No 3():111-5. PubMed ID: 17172245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of interferon beta 1b for multiple sclerosis. Importance of relapses must not be underestimated.
    Cardy P
    BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939142
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon beta in multiple sclerosis.
    Richards RG
    BMJ; 1996 Nov; 313(7066):1159. PubMed ID: 8916730
    [No Abstract]   [Full Text] [Related]  

  • 25. Interferon beta-1a and beta-1b for treatment of multiple sclerosis.
    Kappos L
    Lancet; 2002 Nov; 360(9343):1428; author reply 1428-9. PubMed ID: 12424020
    [No Abstract]   [Full Text] [Related]  

  • 26. Experiences with interferon-beta-1b treatment in MS after three year follow-up.
    Bencsik K; Rajda C; Füvesi J; Járdánházy T; Török M; Vécsei L
    Swiss Med Wkly; 2002 May; 132(17-18):237. PubMed ID: 12087490
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis.
    Penner IK; Stemper B; Calabrese P; Freedman MS; Polman CH; Edan G; Hartung HP; Miller DH; Montalbán X; Barkhof F; Pleimes D; Lanius V; Pohl C; Kappos L; Sandbrink R
    Mult Scler; 2012 Oct; 18(10):1466-71. PubMed ID: 22492127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluation of Avonex (interferon beta-Ia) in patients following a single demyelinating event.
    Iskedjian M; Walker JH; Gray T; Vicente C; Einarson TR; Gehshan A
    Mult Scler; 2005 Oct; 11(5):542-51. PubMed ID: 16193892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular interferon beta-1a and evolving treatment options and outcomes measurement for MS: considerations for managed care.
    Barnes CJ; Caon C; Foley JF; Friedman M; Menzin J; Nair KV; Nichols C; Olvey EL; Owens GM; Pill MW; Skrepnek GH; White LA; Zerkowski K
    J Manag Care Pharm; 2013; 19(1 Suppl A):S1-53. PubMed ID: 23383730
    [No Abstract]   [Full Text] [Related]  

  • 30. Introduction.
    Owens GM
    J Manag Care Pharm; 2013; 19(1 Suppl A):S3. PubMed ID: 23383727
    [No Abstract]   [Full Text] [Related]  

  • 31. [Modifications of the lipid metabolism induced by interferon beta in multiple sclerosis patients and its relationship with the disease activity].
    Ara JR; López A; Martín J; Alarcia R; Oliván JA; de Val V
    Neurologia; 2004 Sep; 19(7):359-63. PubMed ID: 15273882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis.
    Petkau J; White R
    Mult Scler; 1997 Dec; 3(6):402. PubMed ID: 9493643
    [No Abstract]   [Full Text] [Related]  

  • 33. [Interferon beta-1a].
    Taéron C
    Rev Infirm; 2004 May; (101):39-40. PubMed ID: 15984751
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.
    Chellingsworth M
    BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939140
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial: Licensing and Use of New Therapies in MS: Where Are We Going?
    Hurwitz B
    Int MS J; 2005 Aug; 12(2):39-41. PubMed ID: 16417813
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunotherapy of multiple sclerosis. Consensus and controversies].
    Hohlfeld R
    Nervenarzt; 1999 Apr; 70(4):297. PubMed ID: 10354989
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis.
    Duchini A
    Am J Gastroenterol; 2002 Mar; 97(3):767-8. PubMed ID: 11922585
    [No Abstract]   [Full Text] [Related]  

  • 38. Pearls and pitfalls of interferon beta treatment for multiple sclerosis.
    Corona T; León C; Ruiz JL
    Neurologia; 1999 Nov; 14(9):467-8. PubMed ID: 10613023
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon beta-1a and beta-1b for treatment of multiple sclerosis.
    Benatar M
    Lancet; 2002 Nov; 360(9343):1428; author reply 1428-9. PubMed ID: 12424021
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of interferon beta at the time of initial diagnosis of multiple sclerosis.
    Pender MP
    J Clin Neurosci; 2001 Jul; 8(4):381-2. PubMed ID: 11437589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.